Granulocyte colony-stimulating factor (GCSF) gene therapy for treating neurological diseases
US12246074B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 5, 2020 |
| Grant date | Mar 11, 2025 |
| Priority date | — |
| Expiry date | Dec 16, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Gene therapy using expression vectors containing a granulocyte colony-stimulating factor (GCSF) gene are able to protect cells in a cell-based as well as animal-based models for ischemic stroke.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.